Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Crescendo Biologics has appointed Mike Romanos as the new CEO who was the chief scientific officer of the company since May 200.
Subscribe to our email newsletter
As the chief scientific officer, Romanos has led the formation of the company and the development of its proprietary antibody fragment technologies.
Crescendo chairman Clive Dix said that they have seen significant advances in the technology platform and with Mike now taking on the CEO position Crescendo will deliver real value from its proprietary technology platforms.
Crescendo claims that during these time, the company has made significant progress in the establishment of its team and its technology platforms.